Latest Becton Dickinson Stories
FRANKLIN LAKES, N.J., Dec. 19, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor(TM) System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA...
FRANKLIN LAKES, N.J., Nov. 22, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will present at the 23(rd) Annual Piper Jaffray Healthcare Conference on Tuesday, November 29, 2011, at 10:00 a.m. EST. A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors, and will be available for replay through Tuesday, December 6, 2011. BD is a leading global...
FRANKLIN LAKES, N.J., Nov. 22, 2011 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 45 cents per common share, an increase of 4 cents per share, or about 10 percent, from the previous quarter. The dividend will be payable on December 30, 2011 to holders of record on December 12, 2011. At the current rate, the annual dividend for fiscal year 2012 would be $1.80 cents per share. "BD has a...
FRANKLIN LAKES, N.J., Nov. 2, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.051 billion for the fourth fiscal quarter ended September 30, 2011, representing an increase of 9.5 percent from the prior-year period, or 4.0 percent on a foreign currency-neutral basis. For the full fiscal year ended September 30, 2011, BD reported revenues of $7.829 billion, representing an increase of...
FRANKLIN LAKES, N.J., Oct. 31, 2011 /PRNewswire/ -- BD AutoShield(TM) Duo is a next generation, 5mm safety-engineered pen needle designed to protect healthcare workers from needlestick injuries and blood exposure. It is now available in the US from BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company. To view multimedia assets for this release, please click:...
FRANKLIN LAKES, N.J., Oct. 28, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will host an institutional investor and analyst meeting on Wednesday, November 9, 2011, in New York City from 7:45 a.m. - 12:45 p.m. (ET). The meeting will update the investment community on BD's corporate strategy, focusing on investing and innovating for growth. Live webcasts of the 90-minute General Session at 7:45 a.m. and the 30-minute Q & A Session at...
FRANKLIN LAKES, N.J., Oct. 4, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2011 earnings conference call on Wednesday, November 2, 2011, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors...
SANDY, Utah, Sept. 21, 2011 /PRNewswire/ -- A new generation of safety short peripheral IV catheter (SPIVC) technology designed to keep healthcare workers safe from needlestick injuries and blood exposure is now available from BD Medical, a segment of BD (Becton, Dickinson and Company) and the world's leading provider of IV catheters. To view the multimedia assets associated with this release, please click:...
FRANKLIN LAKES, N.J., Sept. 13, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a commitment to Pink Ribbon Red Ribbon®, an innovative initiative to leverage public and private investments in global health to combat cervical and breast cancer led by the George W. Bush Institute, the President's Emergency Plan for AIDS Relief (PEPFAR), Susan G. Komen for the Cure, and the Joint United Nations Programme on...
FRANKLIN LAKES, N.J., Sept. 7, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will present at the 2011 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, at 9:45 a.m. EDT A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors. and will be available for replay through Tuesday, September 20, 2011. BD is a leading global medical technology...
